VERDI ONCOLOGY Trademark
Trademark Overview
On Thursday, March 7, 2019, a trademark application was filed for VERDI ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the VERDI ONCOLOGY trademark a serial number of 88330246. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 8, 2026. This trademark is owned by Verdi Oncology, Inc.. The VERDI ONCOLOGY trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Clinical trial management services in the field of oncology, namely, conducting clinical trials for others
Physician practice management services in the field of oncology; clinical trial management services in the field of oncology, namely, business consulting and management in the field of clinical trials, namely, recommending potentially qualified patients to participate in clinical trials, and coordinating the transmission of clinical data to medical, biopharmaceutical and biotechnology companies to assist them with clinical research and clinical trials
General Information
| Serial Number | 88330246 |
| Word Mark | VERDI ONCOLOGY |
| Filing Date | Thursday, March 7, 2019 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, May 8, 2026 |
| Registration Number | 5889317 |
| Registration Date | Tuesday, October 22, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 6, 2019 |
Trademark Statements
| Goods and Services | Clinical trial management services in the field of oncology, namely, conducting clinical trials for others |
| Translation of Words in Mark | The English translation of "VERDI" in the mark is "green". |
| NOT AVAILABLE | "ONCOLOGY" |
| Goods and Services | Physician practice management services in the field of oncology; clinical trial management services in the field of oncology, namely, business consulting and management in the field of clinical trials, namely, recommending potentially qualified patients to participate in clinical trials, and coordinating the transmission of clinical data to medical, biopharmaceutical and biotechnology companies to assist them with clinical research and clinical trials |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 8, 2026 |
| Primary Code | 035 |
| First Use Anywhere Date | Wednesday, September 30, 2015 |
| First Use In Commerce Date | Wednesday, September 30, 2015 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 8, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, February 23, 2016 |
| First Use In Commerce Date | Tuesday, February 23, 2016 |
Trademark Owner History
| Party Name | Verdi Oncology, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Brentwood, TN 37027
US |
| Party Name | Verdi Oncology, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brentwood, TN 37027
US |
| Party Name | Verdi Oncology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brentwood, TN 37027
US |
Trademark Events
| Event Date | Event Description |
| Monday, March 11, 2019 | NEW APPLICATION ENTERED |
| Tuesday, March 26, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 16, 2019 | ASSIGNED TO EXAMINER |
| Thursday, May 16, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, May 16, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, May 16, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 17, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 17, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 18, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 19, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 1, 2019 | ASSIGNED TO LIE |
| Wednesday, July 17, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 6, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 6, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 22, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, March 28, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, March 28, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 28, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, May 8, 2026 | CANCELLED SEC. 8 (6-YR) |
